Results 21 to 30 of about 2,541 (178)
Navigating Healthcare Economics: Optimizing Therapeutic Efficacy and Cost with Pharmacoeconomics
Journal of Pharmacoeconomics and Pharmaceutical ManagementBackground: In today's healthcare landscape, escalating costs underscore the pressing need for pharmacoeconomic evaluations, particularly in low- and middle-income countries (LMICs) where medication expenses can dominate healthcare budgets ...
Indu Rania, Ray Moumita, Mangal Sudipto
semanticscholar +1 more source
A Cost Variation Analysis of Various Statin Preparations Available in the Egyptian Market
Bulletin of Faculty of Pharmacy Cairo UniversityIntroduction: Dyslipidemia is one of the main risk factors for cardiovascular diseases. Statin preparations are the most effective lipid-lowering preparations that reduce the risk of mortality related to cardiovascular diseases.
Radwa Ahmed Ibrahim +2 more
doaj +1 more source
Pharmacoeconomics in Healthcare By IJISRT
International Journal of Innovative Science and Research TechnologyPharmacoeconomics is the study of the cost- effectiveness and accessibility of pharmaceutical treatments from the perspective of both individuals and the healthcare system as a whole.
Apoorva Mahendrakar +5 more
semanticscholar +1 more source
Pharmacoeconomics and Health Technology Assessment - Letter to the Editor
Bulletin of Faculty of Pharmacy Cairo UniversityThis is letter to the ...
Samar Farid
doaj +1 more source
Bulletin of Faculty of Pharmacy Cairo UniversityBackground: According to the CASTOR trial, DARA is shown to be effective as a second line for RRMM patients either as monotherapy or in combination with the gold standard regimen.
Menna M. ElSherbiny +2 more
doaj +1 more source
The Open Public Health JournalPharmacoeconomics (PE), a part of health economics (HE), focuses on evaluating therapeutic options for treating diseases by identifying, measuring, and comparing the costs of pharmaceutical interventions and their outcomes. Its purpose is to help and
S. Alsahali
semanticscholar +1 more source
Pharmacoeconomics Status in Asia and an Emerging Hub in the Indo-Pak
Indian Journal of Pharmaceutical Education and Research, 2019 Objective: A review has been carried out to understand pharmacoeconomics and its development in the Asian region. Findings: Pharmacoeconomics is a subset of health economics which applies the methodologies and principles of health economics in clinical ...
Halima Sadia, H. Rehman, S. Naveed
semanticscholar +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
British Journal of Clinical Pharmacology, EarlyView.Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Cost Variation Analysis of Oral Hypoglycemic Drugs in the Egyptian Market
Bulletin of Faculty of Pharmacy Cairo UniversityIntroduction: Type II diabetes mellitus is a lifelong condition requiring lifelong medication. This study aims to analyze the cost variation of the oral hypoglycemic drugs in the Egyptian pharmaceutical market.
George G. Abdelmessih +2 more
doaj +1 more source
A brief overview on the use of probiotics to treat overweight and obese patients
Expert Review of Endocrinology & Metabolism, 2020 Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran; Department of Toxicology and Pharmacology, School of Pharmacy ...
M. Daniali, S. Nikfar, M. Abdollahi
semanticscholar +1 more source